GlassScriptPhysician profile
Daniel Hafenrichter
NPI 1063483139
$15,184.56
in general payments reported to CMS, 2019-2025
22 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $13K · 2021: $245 · 2022: $396 · 2023: $346 · 2024: $528 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,814.40 | 2019-2024 | |
| Davol INC. | $871.12 | 2019-2025 | Phasix Mesh |
| Ethicon INC. | $403.26 | 2019 | |
| W. L. Gore & Associates, INC. | $303.02 | 2019-2024 | Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $221.93 | 2019-2023 | Echelon Flex |
| Janssen Pharmaceuticals, INC | $93.34 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $64.79 | 2020-2022 | |
| Medtronic, INC. | $57.87 | 2021-2023 | Signia |
| Medtronic Vascular, INC. | $55.56 | 2019-2020 | |
| Baxter Healthcare | $42.38 | 2019 | |
| Integra Lifesciences Corporation | $40.08 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Smith+Nephew, INC. | $36.64 | 2021 | |
| Lemaitre Vascular, INC. | $26.06 | 2022 | |
| Lsi Solutions INC | $23.80 | 2023 | Ti Knot |
| Allergan, INC. | $21.72 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $19.73 | 2022 | |
| Abbvie INC. | $17.28 | 2023 | |
| Fresenius Kabi USA, LLC | $16.32 | 2020 | |
| Acell, INC. | $15.43 | 2019 | |
| Pfizer INC. | $13.75 | 2019 | |
| Polynovo North America LLC | $13.07 | 2021 | |
| Covidien LP | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hafenrichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.